An analysis of hospital admissions from 1991 to 2007 for 17,472 men who underwent prostate biopsy and 134,977 controls revealed a 30-day hospitalization rate of 6.9% within 30 days of biopsy—substantially higher than the 2.7% in the control population.
Men hospitalized with biopsy-related infections had mortality risk 12 times higher than men who did not undergo the procedure. More recent year of biopsy, nonwhite race, and higher comorbidity scores were significantly associated with an increased risk of infectious complications of biopsy.
While infectious complications post-biopsy have increased since 2000, the rate of serious noninfectious complications is relatively stable Edward M. Schaeffer, MD, PhD, and colleagues reported online in The Journal of Urology. The researchers recommend careful patient selection for prostate biopsy.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.